Clinical trial
Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of…
NCT00261950 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00261950 |
|---|---|
| Title | Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease |
| Official title | Bone Histomorphometry Assessment For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease |
| Acronym | BONAFIDE |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Sensipar (Cinacalcet HCl) |
| Enrollment | 110 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Dec 6, 2005 |
| Last update posted | Jul 21, 2014 |
| Countries | Belgium, Czechia, Hungary, Italy, North Macedonia, Poland, Portugal, Spain, Switzerland, Turkey (Türkiye), United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: